Compare GSK plc (GSK) vs KeyCorp (KEY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs KeyCorp — how do they compare? GSK plc trades at $50.64 (market cap $102.60B), while KeyCorp trades at $22.7 (market cap $24.32B). The key difference: GSK plc is far larger — about 4.2× KeyCorp's market cap, and KeyCorp pays the higher dividend (3.61%). Which is the better fit depends on your goals.
| GSK | KEY | |
|---|---|---|
Market Cap | $102.60B | $24.32B |
Sector | Health | Financials |
52-Week High | $61.18 | $23.99 |
52-Week Low | $38.22 | $16.78 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | 3.61% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →
